TNF and rheumatoid arthritis: The success of therapeutics for RA that target either T cells or TNF-α strongly implicates these factors in this disease in humans, however some RA patients are refractory to these treatments, develop antibodies that neutralize these biologics, or experience various side effects that can range from mild (e.g., rash) to severe (e.g., sepsis) [5,6].